624 related articles for article (PubMed ID: 24376655)
1. Targeting CD28, CTLA-4 and PD-L1 costimulation differentially controls immune synapses and function of human regulatory and conventional T-cells.
Dilek N; Poirier N; Hulin P; Coulon F; Mary C; Ville S; Vie H; Clémenceau B; Blancho G; Vanhove B
PLoS One; 2013; 8(12):e83139. PubMed ID: 24376655
[TBL] [Abstract][Full Text] [Related]
2. Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells.
Tekguc M; Wing JB; Osaki M; Long J; Sakaguchi S
Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34301886
[TBL] [Abstract][Full Text] [Related]
3. A transendocytosis model of CTLA-4 function predicts its suppressive behavior on regulatory T cells.
Hou TZ; Qureshi OS; Wang CJ; Baker J; Young SP; Walker LS; Sansom DM
J Immunol; 2015 Mar; 194(5):2148-59. PubMed ID: 25632005
[TBL] [Abstract][Full Text] [Related]
4. CD86 Is a Selective CD28 Ligand Supporting FoxP3+ Regulatory T Cell Homeostasis in the Presence of High Levels of CTLA-4.
Halliday N; Williams C; Kennedy A; Waters E; Pesenacker AM; Soskic B; Hinze C; Hou TZ; Rowshanravan B; Janman D; Walker LSK; Sansom DM
Front Immunol; 2020; 11():600000. PubMed ID: 33363541
[TBL] [Abstract][Full Text] [Related]
5. Enhanced suppression of polyclonal CD8
Mu C; Zhang X; Wang L; Xu A; Ahmed KA; Pang X; Chibbar R; Freywald A; Huang J; Zhu Y; Xiang J
J Leukoc Biol; 2017 May; 101(5):1221-1231. PubMed ID: 28096300
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
[TBL] [Abstract][Full Text] [Related]
7. TCR Signaling and CD28/CTLA-4 Signaling Cooperatively Modulate T Regulatory Cell Homeostasis.
Holt MP; Punkosdy GA; Glass DD; Shevach EM
J Immunol; 2017 Feb; 198(4):1503-1511. PubMed ID: 28053234
[TBL] [Abstract][Full Text] [Related]
8. Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4.
Qureshi OS; Zheng Y; Nakamura K; Attridge K; Manzotti C; Schmidt EM; Baker J; Jeffery LE; Kaur S; Briggs Z; Hou TZ; Futter CE; Anderson G; Walker LS; Sansom DM
Science; 2011 Apr; 332(6029):600-3. PubMed ID: 21474713
[TBL] [Abstract][Full Text] [Related]
9. B7-1/B7-2 blockade overrides the activation of protective CD8 T cells stimulated in the absence of Foxp3+ regulatory T cells.
Ertelt JM; Buyukbasaran EZ; Jiang TT; Rowe JH; Xin L; Way SS
J Leukoc Biol; 2013 Aug; 94(2):367-76. PubMed ID: 23744647
[TBL] [Abstract][Full Text] [Related]
10. PD-1 or CTLA-4 blockade promotes CD86-driven Treg responses upon radiotherapy of lymphocyte-depleted cancer in mice.
Frijlink E; Bosma DM; Busselaar J; Battaglia TW; Staal MD; Verbrugge I; Borst J
J Clin Invest; 2024 Feb; 134(6):. PubMed ID: 38349740
[TBL] [Abstract][Full Text] [Related]
11. Regulatory T Cell-Dependent and -Independent Mechanisms of Immune Suppression by CD28/B7 and CD40/CD40L Costimulation Blockade.
Vogel I; Verbinnen B; Van Gool S; Ceuppens JL
J Immunol; 2016 Jul; 197(2):533-40. PubMed ID: 27288533
[TBL] [Abstract][Full Text] [Related]
12. PD-L1:CD80 Cis-Heterodimer Triggers the Co-stimulatory Receptor CD28 While Repressing the Inhibitory PD-1 and CTLA-4 Pathways.
Zhao Y; Lee CK; Lin CH; Gassen RB; Xu X; Huang Z; Xiao C; Bonorino C; Lu LF; Bui JD; Hui E
Immunity; 2019 Dec; 51(6):1059-1073.e9. PubMed ID: 31757674
[TBL] [Abstract][Full Text] [Related]
13. Targeting T cell costimulation in autoimmune disease.
Stuart RW; Racke MK
Expert Opin Ther Targets; 2002 Jun; 6(3):275-89. PubMed ID: 12223069
[TBL] [Abstract][Full Text] [Related]
14. By Binding CD80 and CD86, the Vaccinia Virus M2 Protein Blocks Their Interactions with both CD28 and CTLA4 and Potentiates CD80 Binding to PD-L1.
Kleinpeter P; Remy-Ziller C; Winter E; Gantzer M; Nourtier V; Kempf J; Hortelano J; Schmitt D; Schultz H; Geist M; Brua C; Hoffmann C; Schlesinger Y; Villeval D; Thioudellet C; Erbs P; Foloppe J; Silvestre N; Fend L; Quemeneur E; Marchand JB
J Virol; 2019 Jun; 93(11):. PubMed ID: 30918073
[TBL] [Abstract][Full Text] [Related]
15. CD28/CTLA-4/B7 costimulatory pathway blockade affects regulatory T-cell function in autoimmunity.
Vogel I; Kasran A; Cremer J; Kim YJ; Boon L; Van Gool SW; Ceuppens JL
Eur J Immunol; 2015 Jun; 45(6):1832-41. PubMed ID: 25727069
[TBL] [Abstract][Full Text] [Related]
16. miR-424(322) reverses chemoresistance via T-cell immune response activation by blocking the PD-L1 immune checkpoint.
Xu S; Tao Z; Hai B; Liang H; Shi Y; Wang T; Song W; Chen Y; OuYang J; Chen J; Kong F; Dong Y; Jiang SW; Li W; Wang P; Yuan Z; Wan X; Wang C; Li W; Zhang X; Chen K
Nat Commun; 2016 May; 7():11406. PubMed ID: 27147225
[TBL] [Abstract][Full Text] [Related]
17. Murine regulatory T cells differ from conventional T cells in resisting the CTLA-4 reversal of TCR stop-signal.
Lu Y; Schneider H; Rudd CE
Blood; 2012 Nov; 120(23):4560-70. PubMed ID: 23047820
[TBL] [Abstract][Full Text] [Related]
18. Control of Memory Phenotype T Lymphocyte Homeostasis: Role of Costimulation.
Panda AK; Kim YH; Shevach EM
J Immunol; 2022 Feb; 208(4):851-860. PubMed ID: 35039334
[TBL] [Abstract][Full Text] [Related]
19. CD28-CD80 interactions control regulatory T cell motility and immunological synapse formation.
Thauland TJ; Koguchi Y; Dustin ML; Parker DC
J Immunol; 2014 Dec; 193(12):5894-903. PubMed ID: 25355918
[TBL] [Abstract][Full Text] [Related]
20. Programmed Death-Ligand 1 on Antigen-presenting Cells Facilitates the Induction of Antigen-specific Cytotoxic T Lymphocytes: Application to Adoptive T-Cell Immunotherapy.
Goto T; Nishida T; Takagi E; Miyao K; Koyama D; Sakemura R; Hanajiri R; Watanabe K; Imahashi N; Terakura S; Murata M; Kiyoi H
J Immunother; 2016 Oct; 39(8):306-15. PubMed ID: 27548033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
